Between 2024 and 2028, the US biotechnology scientific publications are expected to gradually decrease from 1,380 to 1,320 publications. The decline signifies roughly a 1% year-on-year decrease during this period. In 2023, there were approximately 1,400 publications, highlighting an ongoing downward trend. The average compound annual growth rate (CAGR) from 2024 to 2028 indicates a slight decline in publication volumes.

Future trends to watch include:

Increased emphasis on interdisciplinary research may counteract declining publications.
Potential impacts of funding fluctuation and regulatory changes.
Emerging biotechnology fields possibly spurring new research avenues.